We are live on ! Find out more
RIGL icon

Rigel Pharmaceuticals
RIGL

96 hedge funds and large institutions have $172M invested in Rigel Pharmaceuticals in 2014 Q4 according to their latest regulatory filings, with 12 funds opening new positions, 23 increasing their positions, 41 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed

13% more capital invested

Capital invested by funds: $153M → $172M (+$19.7M)

8% less funds holding

Funds holding: 104 → 96 (-8)

33% less first-time investments, than exits

New positions opened: 12 | Existing positions closed: 18

44% less repeat investments, than reductions

Existing positions increased: 23 | Existing positions reduced: 41

Holders
96
Holders Change
-8
Holders Change %
-7.69%
% of All Funds
2.56%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
12
Increased
23
Reduced
41
Closed
18
Calls
$3K
Puts
–
Net Calls
+$3K
Net Calls Change
+$2K

Top Buyers

1
BC
Broadfin Capital
New York
+$5.06M
2
DCM
DAFNA Capital Management
California
+$1.51M
3
California Public Employees Retirement System
California Public Employees Retirement System
California
+$1.16M
4
Marshall Wace
Marshall Wace
United Kingdom
+$735K
5
OAM
Oxford Asset Management
United Kingdom
+$376K

Top Sellers

1
Millennium Management
Millennium Management
New York
-$2.2M
2
BFA
BlackRock Fund Advisors
California
-$1.55M
3
TC
TFS Capital
Pennsylvania
-$1.54M
4
Vanguard Group
Vanguard Group
Pennsylvania
-$1.48M
5
Adage Capital Partners
Adage Capital Partners
Massachusetts
-$1.16M
Name Holding Trade Value Shares
Change 		Change in
Stake
California State Teachers Retirement System (CalSTRS)
51
California State Teachers Retirement System (CalSTRS)
California
$367K +$1.4K +69 +0.4%
Nomura Holdings
52
Nomura Holdings
Japan
$317K +$272K +13,437 New
USAA
53
United Services Automobile Association
Texas
$292K +$12K +593 +5%
RhumbLine Advisers
54
RhumbLine Advisers
Massachusetts
$284K +$21K +1,038 +9%
Morgan Stanley
55
Morgan Stanley
New York
$275K -$82.4K -4,076 -25%
TA
56
Teachers Advisors
New York
$273K – – –
PRC
57
Platte River Capital
Colorado
$223K +$1.01K +50 +0.5%
VOYA Investment Management
58
VOYA Investment Management
Georgia
$215K -$40 -2 -0%
NI
59
Numeric Investors
Massachusetts
$194K -$443K -21,928 -72%
State Board of Administration of Florida Retirement System
60
State Board of Administration of Florida Retirement System
Florida
$186K – – –
MLICM
61
Metropolitan Life Insurance Company (MetLife)
New York
$174K +$155K +7,650 New
PPA
62
Parametric Portfolio Associates
Washington
$160K +$52.3K +2,584 +58%
FSA
63
Franklin Street Advisors
North Carolina
$159K -$202K -10,000 -59%
Balyasny Asset Management
64
Balyasny Asset Management
Illinois
$145K -$1.12M -55,623 -90%
Invesco
65
Invesco
Georgia
$143K +$6.51K +322 +5%
PP
66
Paloma Partners
Connecticut
$134K +$27.3K +1,350 +30%
AIG
67
American International Group
New York
$125K -$4.41K -218 -4%
AL
68
Airain Ltd
Guernsey
$114K +$101K +5,002 New
DekaBank Deutsche Girozentrale
69
DekaBank Deutsche Girozentrale
Germany
$106K -$9.1K -450 -9%
CS
70
Credit Suisse
Switzerland
$98K -$160K -7,919 -65%
Public Employees Retirement Association of Colorado
71
Public Employees Retirement Association of Colorado
Colorado
$86K – – –
Susquehanna International Group
72
Susquehanna International Group
Pennsylvania
$65K -$7.42K -367 -11%
SIM
73
Spark Investment Management
New York
$59K +$53K +2,620 New
ARTA
74
A.R.T. Advisors
New York
$57K +$2.47K +122 +5%
VKH
75
Virtu KCG Holdings
New York
$51K +$8.03K +397 +22%
1 2
3
4 5

RIGL Hedge Fund Activity: Q4 2014 in Review

96 of the 3,749 institutional investors tracked by Wall St. Rank reported a position in Rigel Pharmaceuticals (RIGL) for Q4 2014, worth a combined $172M — up 13% from $153M a quarter earlier.

Sellers outnumbered buyers: 18 funds closed out of RIGL and 12 opened new positions — a net loss of 6 holders — while 41 trimmed existing stakes and 23 added.

The largest buyer was Broadfin Capital, adding an estimated $5.06M. The largest seller was Millennium Management, cutting an estimated $2.2M.

  • 96 institutional investors held Rigel Pharmaceuticals (RIGL) as of Q4 2014, down from 104 in Q3 2014.
  • Funds reported $172M of Rigel Pharmaceuticals stock for Q4 2014, up 13% quarter-over-quarter.
  • 12 funds opened new Rigel Pharmaceuticals positions in Q4 2014 and 18 closed out, a net change of -6 holders.
  • The largest Rigel Pharmaceuticals buyer in Q4 2014 was Broadfin Capital, an estimated $5.06M added.
  • The largest Rigel Pharmaceuticals seller in Q4 2014 was Millennium Management, an estimated $2.2M sold.

Based on aggregated 13F filings for Q4 2014.